Is there a significant price difference between brand name and generic tigecycline?

Why do brand-name and generic prices differ for tigecycline?

Brand-name tigecycline sells under the brand Tygacil. The generic versions enter the market only after the original patent expires. Generics typically cost 80-90% less than the brand because they avoid the heavy research and marketing expenses carried by the original developer.

When does the Tygacil patent expire?

Tygacil's compound patent expired in 2016. The pediatric exclusivity period ran until June 2019. Since then, multiple manufacturers have launched generic versions, sharpening price competition.

Can generics undercut prices further?

Multiple companies now produce generic tigecycline. The entry of several suppliers has already lowered prices substantially. Further reductions occur whenever a new competitor joins the market and offers even lower rates.

What side effects should patients ask about?

Both brand and generic tigecycline share the same side-effect profile. Patients report nausea, vomiting, diarrhea, and increased risk of superinfection. The active ingredient remains unchanged, so risk behavior stays identical.

How does tigecycline compare with linezolid?

Tigecycline covers a broader spectrum of bacteria than linezolid. It works against methicillin-resistant Staphylococcus aureus (MRSA) and many gram-negative organisms. Linezolid focuses mainly on gram-positive bacteria.